Deflazacort

Overview

Deflazacort is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL1201891).

API suppliers (2)

Suppliers of Deflazacort backed by a verifiable FDA Type II Drug Master File. Source: FDA quarterly DMF list.

• SYMBIOTEC PHARMALAB PRIVATE LTD1 active DMF
• SCHERING AG

Patent & exclusivity (US)

Per the FDA Orange Book (31 approved US products), the latest listed US patent on Deflazacort expires — and exclusivity 6 Jun 2026. Generic API sourcing typically opens up once these lapse.

Chemical identity

IUPAC name

[2-[(1S,2S,4R,8S,9S,11S,12S,13R)-11-hydroxy-6,9,13-trimethyl-16-oxo-5-oxa-7-azapentacyclo[10.8.0.02,9.04,8.013,18]icosa-6,14,17-trien-8-yl]-2-oxoethyl] acetate

Canonical SMILES

CC1=N[C@@]2([C@H](O1)C[C@@H]3[C@@]2(C[C@@H]([C@H]4[C@H]3CCC5=CC(=O)C=C[C@]45C)O)C)C(=O)COC(=O)C

InChIKey

FBHSPRKOSMHSIF-GRMWVWQJSA-N